Tembexa
- Product NDC
- 79622-012
- 11-digit product format
- 796220012
- Labeler code
- 79622
- Product ID
- 79622-012_2f140fb3-5828-484b-b006-529b7f31c036
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Brincidofovir
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Chimerix, Inc.
- Application
- NDA214460
- Marketing category
- NDA
- Marketing start
- 2022-04-20
- Marketing end
- 0000-00-00
- Substance
- BRINCIDOFOVIR
- Active strength
- 10 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 79622-012-65 | Tembexa | 65 mL in 1 BOTTLE | SUSPENSION | 65 | | 4 |
| 79622-012-70 | Tembexa | 65 mL in 1 BOTTLE | SUSPENSION | 65 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 79622-012 | TEMBEXA (BRINCIDOFOVIR) SUSPENSION [CHIMERIX, INC.] | 4 | Legacy NDC, 2 package rows | 20220422_12569e7c-9c2a-4b8b-94e2-f05607b4a866.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 79622-012-65 | 79622001265 | 65 mL in 1 BOTTLE (79622-012-65) | 65 ml | 2022-04-20 | 0000-00-00 | No | No | Current |
| 79622-012-70 | 79622001270 | 65 mL in 1 BOTTLE (79622-012-70) | 65 ml | 2022-04-20 | 0000-00-00 | No | No | Current |